List of Excipients in API irinotecan hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing irinotecan hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Pharmacia & Upjohn Company LLC | CAMPTOSAR | irinotecan hydrochloride | 0009-7529 | HYDROCHLORIC ACID | |
| Pharmacia & Upjohn Company LLC | CAMPTOSAR | irinotecan hydrochloride | 0009-7529 | LACTIC ACID | |
| Pharmacia & Upjohn Company LLC | CAMPTOSAR | irinotecan hydrochloride | 0009-7529 | SODIUM HYDROXIDE | |
| Ipsen Biopharmaceuticals Inc | ONIVYDE | irinotecan hydrochloride | 15054-0043 | 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE | |
| Ipsen Biopharmaceuticals Inc | ONIVYDE | irinotecan hydrochloride | 15054-0043 | CHOLESTEROL | |
| Ipsen Biopharmaceuticals Inc | ONIVYDE | irinotecan hydrochloride | 15054-0043 | HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing irinotecan hydrochloride
Detailed excipient profiles for irinotecan hydrochloride
Excipient focus: 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE
irinotecan hydrochloride drug variants containing 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE
| Company | Ingredient | NDC |
|---|---|---|
| Ipsen Biopharmaceuticals Inc | irinotecan hydrochloride | 15054-0043 |
| >Company | >Ingredient | >NDC |
irinotecan hydrochloride drug variants not containing 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE
Excipient focus: CHOLESTEROL
irinotecan hydrochloride drug variants containing CHOLESTEROL
| Company | Ingredient | NDC |
|---|---|---|
| Ipsen Biopharmaceuticals Inc | irinotecan hydrochloride | 15054-0043 |
| >Company | >Ingredient | >NDC |
irinotecan hydrochloride drug variants not containing CHOLESTEROL
Excipient focus: HYDROCHLORIC ACID
irinotecan hydrochloride drug variants containing HYDROCHLORIC ACID
irinotecan hydrochloride drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Ipsen Biopharmaceuticals Inc | irinotecan hydrochloride | 15054-0043 |
| Areva PharmaceuticalsInc | irinotecan hydrochloride | 59923-702 |
| BluePoint Laboratories | irinotecan hydrochloride | 68001-284 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID
irinotecan hydrochloride drug variants containing HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Ipsen Biopharmaceuticals Inc | irinotecan hydrochloride | 15054-0043 |
| >Company | >Ingredient | >NDC |
irinotecan hydrochloride drug variants not containing HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID
Excipient focus: LACTIC ACID
irinotecan hydrochloride drug variants containing LACTIC ACID
irinotecan hydrochloride drug variants not containing LACTIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Ipsen Biopharmaceuticals Inc | irinotecan hydrochloride | 15054-0043 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
irinotecan hydrochloride drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Ipsen Biopharmaceuticals Inc | irinotecan hydrochloride | 15054-0043 |
| >Company | >Ingredient | >NDC |
irinotecan hydrochloride drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM HYDROXIDE
irinotecan hydrochloride drug variants containing SODIUM HYDROXIDE
irinotecan hydrochloride drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Ipsen Biopharmaceuticals Inc | irinotecan hydrochloride | 15054-0043 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE
irinotecan hydrochloride drug variants containing SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE
| Company | Ingredient | NDC |
|---|---|---|
| Ipsen Biopharmaceuticals Inc | irinotecan hydrochloride | 15054-0043 |
| >Company | >Ingredient | >NDC |
irinotecan hydrochloride drug variants not containing SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE
Excipient focus: SORBITOL
irinotecan hydrochloride drug variants containing SORBITOL
irinotecan hydrochloride drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | irinotecan hydrochloride | 0009-7529 |
| Ipsen Biopharmaceuticals Inc | irinotecan hydrochloride | 15054-0043 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
irinotecan hydrochloride drug variants containing WATER
irinotecan hydrochloride drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
